Merck (BSE:MRK) Forward Dividend Yield % : 0.00% (As of May. 06, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Merck Forward Dividend Yield %?

As of today (2024-05-06), the Forward Annual Dividend Yield of Merck is 0.00%.

As of today (2024-05-06), the Trailing Annual Dividend Yield of Merck is 0.00%.

BSE:MRK's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.81
* Ranked among companies with meaningful Forward Dividend Yield % only.

Merck's Dividends per Share for the three months ended in Mar. 2024 was lei0.00.

During the past 12 months, Merck's average Dividends Per Share Growth Rate was 5.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 6.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Merck was 109.50% per year. The lowest was 0.40% per year. And the median was 8.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Merck's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, Merck's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Merck's Forward Dividend Yield % falls into.

Merck Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Merck (BSE:MRK) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Merck Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Merck's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BSE:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSE:MRK) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.